We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
-20.55%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$761M
AUM Growth
+$324M
(+74%)
Cap. Flow
+$462M
Cap. Flow
% of AUM
60.75%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
1,302
New
602
Increased
163
Reduced
60
Closed
477
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$15.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$9.6M |
| 3 |
HCA Healthcare
HCA
|
+$8.15M |
| 4 |
ConocoPhillips
COP
|
+$8.08M |
| 5 |
Illumina
ILMN
|
+$7.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$7.5M |
| 2 |
Realty Income
O
|
+$4.54M |
| 3 |
Zimmer Biomet
ZBH
|
+$4.2M |
| 4 |
American Airlines Group
AAL
|
+$4.17M |
| 5 |
Dow Inc
DOW
|
+$3.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.21% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Financials | 12.51% |
| 4 | Industrials | 11.01% |
| 5 | Healthcare | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Viemed Healthcare
VMD
$459M
| $79K | 0.01% |
+14,721
| New | +$79.4K |
|
727
Vera Bradley
VRA
$104M
| $79K | 0.01% |
+18,307
| New | +$112K |
|
728
Melco Resorts & Entertainment
MLCO
$2.21B
| $78K | 0.01% |
+13,587
| New | +$79.7K |
|
729
Citizens
CIA
$263M
| $77K | 0.01% |
+18,387
| New | +$66.3K |
|
|
MOMO
730
Hello Group
MOMO
$876M
| $77K | 0.01% |
+15,276
| New | +$80.1K |
|
|
DMTK
731
DELISTED
DermTech, Inc. Common Stock
DMTK
| $75K | 0.01% |
+13,616
| New | +$111K |
|
732
Ceco Environmental
CECO
$3.85B
| $74K | 0.01% |
+12,301
| New | +$68.2K |
|
733
Commercial Vehicle Group
CVGI
$149M
| $73K | 0.01% |
+12,504
| New | +$85.1K |
|
734
ImmunityBio
IBRX
$7.26B
| $72K | 0.01% |
+19,223
| New | +$77.2K |
|
735
Latham Group
SWIM
$667M
| $72K | 0.01% |
+10,358
| New | +$110K |
|
736
Lineage Cell Therapeutics
LCTX
$262M
| $71K | 0.01% |
+44,829
| New | +$59.1K |
|
|
SFIX
737
Stitch Fix
SFIX
$566M
| $70K | 0.01% |
+14,127
| New | +$118K |
|
|
CBAY
738
DELISTED
Cymabay Therapeutics
CBAY
| $70K | 0.01% |
+23,644
| New | +$56.5K |
|
739
MannKind Corp
MNKD
$1.2B
| $63K | 0.01% |
+16,609
| New | +$61K |
|
740
Coeur Mining
CDE
$14.8B
| $62K | 0.01% |
+20,308
| New | +$79.8K |
|
|
LUNA
741
DELISTED
Luna Innovations Incorporated
LUNA
| $62K | 0.01% |
+10,667
| New | +$62.9K |
|
742
SGHC Ltd
SGHC
$7.65B
| $61K | 0.01% |
+14,790
| New | +$114K |
|
|
KG
743
Kestrel Group
KG
$68M
| $60K | 0.01% |
+1,541
| New | +$68.9K |
|
744
Nuvation Bio
NUVB
$2.31B
| $60K | 0.01% |
+18,398
| New | +$80.2K |
|
745
Comscore
SCOR
$112M
| $57K | 0.01% |
+1,383
| New | +$57.5K |
|
746
Harvard Bioscience
HBIO
$27.1M
| $53K | 0.01% |
+1,464
| New | +$66.1K |
|
|
IDEX
747
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $53K | 0.01% |
+635
| New | +$57.2K |
|
|
ITI
748
DELISTED
Iteris, Inc.
ITI
| $52K | 0.01% |
+17,832
| New | +$49.6K |
|
|
ENDP
749
DELISTED
Endo International plc
ENDP
| $52K | 0.01% |
+112,538
| New | +$143K |
|
|
HUT
750
Hut 8
HUT
$10.6B
| $50K | 0.01% |
+7,326
| New | +$109K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q2 2022 Portfolio in Review
As of Q2 2022, Y-Intercept (HK) held 1,302 positions worth $761M, up 74% from $437M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Y-Intercept (HK) deployed $462M of net new capital in Q2 2022, opening 602 new positions and adding to 163 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 30,610 shares worth $8.36M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was CenterPoint Energy, an estimated $1.92M trimmed.
- Y-Intercept (HK)'s largest Q2 2022 buy was Berkshire Hathaway Class B: 30,610 shares worth $8.36M.
- Y-Intercept (HK) added most to Apple in Q2 2022, an estimated $15.9M increase.
- Y-Intercept (HK)'s biggest Q2 2022 reduction was CenterPoint Energy, cutting an estimated $1.92M.
- Y-Intercept (HK) fully exited Linde in Q2 2022, selling an estimated $7.5M.
- Y-Intercept (HK)'s ten largest holdings make up 9.8% of its $761M portfolio in Q2 2022.
- Y-Intercept (HK) opened 602 new positions and closed 477 in Q2 2022.
- Y-Intercept (HK)'s portfolio value rose 74% quarter-over-quarter to $761M.
Based on Y-Intercept (HK)'s 13F filing for Q2 2022, filed 8 Aug 2022.